Literature DB >> 35228036

Structural aspects of the MHC expression control system.

Grady Nash1, Bhaskar Paidimuddala1, Liman Zhang2.   

Abstract

The major histocompatibility complex (MHC) spans innate and adaptive immunity by presenting antigenic peptides to CD4+ and CD8+ T cells. Multiple transcription factors form an enhanceosome complex on the MHC promoter and recruit transcriptional machinery to activate gene transcription. Immune signals such as interferon-γ (IFN-γ) control MHC level by up-regulating components of the enhanceosome complex. As MHC plays crucial roles in immune regulation, alterations in the MHC enhanceosome structure will alter the pace of rapid immune responses at the transcription level and lead to various diseases related to the immune system. In this review, we discuss the current understanding of the MHC enhanceosome, with a focus on the structures of MHC enhanceosome components and the molecular basis of MHC enhanceosome assembly.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CIITA; MHC enhanceosome; NLR; NLRC5; Proteins; Structural biology; Transcription factors

Mesh:

Substances:

Year:  2022        PMID: 35228036      PMCID: PMC8941990          DOI: 10.1016/j.bpc.2022.106781

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  90 in total

1.  CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.

Authors:  K Masternak; A Muhlethaler-Mottet; J Villard; M Zufferey; V Steimle; W Reith
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

2.  The NACHT family - a new group of predicted NTPases implicated in apoptosis and MHC transcription activation.

Authors:  E V Koonin; L Aravind
Journal:  Trends Biochem Sci       Date:  2000-05       Impact factor: 13.807

3.  The N-terminal domain of NLRC5 confers transcriptional activity for MHC class I and II gene expression.

Authors:  Andreas Neerincx; Kristin Jakobshagen; Olaf Utermöhlen; Hildegard Büning; Viktor Steimle; Thomas A Kufer
Journal:  J Immunol       Date:  2014-08-15       Impact factor: 5.422

4.  Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.

Authors:  T Scholl; S K Mahanta; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

5.  Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression.

Authors:  Eleni Zika; Lucas Fauquier; Laurence Vandel; Jenny P-Y Ting
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-27       Impact factor: 11.205

Review 6.  Combined immunodeficiency with defective expression in MHC class II genes.

Authors:  C Griscelli; B Lisowska-Grospierre; B Mach
Journal:  Immunodefic Rev       Date:  1989

7.  Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters.

Authors:  S L Hasegawa; J M Boss
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

8.  The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2.

Authors:  Claudio Casoli; Andrea De Lerma Barbaro; Elisabetta Pilotti; Umberto Bertazzoni; Giovanna Tosi; Roberto S Accolla
Journal:  Blood       Date:  2003-10-02       Impact factor: 22.113

9.  The structural basis of flagellin detection by NAIP5: A strategy to limit pathogen immune evasion.

Authors:  Jeannette L Tenthorey; Nicole Haloupek; José Ramón López-Blanco; Patricia Grob; Elise Adamson; Ella Hartenian; Nicholas A Lind; Natasha M Bourgeois; Pablo Chacón; Eva Nogales; Russell E Vance
Journal:  Science       Date:  2017-11-17       Impact factor: 47.728

Review 10.  The dual function of the MHC class II transactivator CIITA against HTLV retroviruses.

Authors:  Giovanna Tosi; Luisa Bozzo; Roberto S Accolla
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  1 in total

1.  Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer.

Authors:  Nelson K Y Wong; Xin Dong; Yen-Yi Lin; Hui Xue; Rebecca Wu; Dong Lin; Colin Collins; Yuzhuo Wang
Journal:  Cells       Date:  2022-05-05       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.